In Vivo Investigation of 6 Membranes Including Their Physical, Chemical &

Status Completed

Clinical Trial Summary

A wide range of resorbable and non-resorbable membranes have been investigated over the last decades. Barrier membranes protect bone defects from ingrowth of soft tissue cells, provide mechanical stability of the defect area and allow bone progenitor cells to develop within a blood clot that is formed beneath the barrier membrane, taking a minimum of four to six weeks for periodontal tissues and 16-24 weeks for bone1,2.These membranes are utilized to reconstruct bone defects prior to implantation and to cover dehiscences and fenestrations around dental implants. When aiming to regenerate bone, resorbable or a non - resorbable membranes should be selected depending on location, size and defect area. However, until now the ideal membrane has not been described due to different opinions between authors3,4. Nevertheless, an ideal membrane should maintain its barrier function enough time for new bone formation, and if possible should be resorbable, so that a second surgical procedure for the explantation of the membrane would not be required, thus reducing the morbidity5. However, the use of a barrier membrane is a technique-sensitive procedure that is not free of complications. The main cause of Guided Bone Regeneration (GBR) failure is related to early or late exposure of the membrane, leading to contamination and infection of the biomaterial, irreversibly compromising bone regeneration4,6,7. Consequently, the inflammatory reaction of the surrounding soft tissues may require early removal of the membrane. Other complications, such as the onset of an abscess with purulent exudate, can also lead to a complete failure of GBR even without exposure of the membrane. It is thought necessary to perform this clinical study due to the lack of information present in the literature about the different types of membranes that exist nowadays, how they act in the human body with or without performing some type of regeneration and how our body acts towards them.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05443776
Study type	Interventional
Source	Universitat Internacional de Catalunya
Contact
Status	Completed
Phase	N/A
Start date	September 15, 2019
Completion date	March 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04744012` - Modified Periostal Pocket Flap Technique
Completed	`NCT03497403` - Socket Preservation Procedure Studying Soft and Hard Tissue Outcomes	N/A
Recruiting	`NCT04149080` - Effects of Simvastatin Gel on Bone Neoformation in Post-extraction Sockets: a Randomized Controlled Trial	N/A
Completed	`NCT04205591` - Comparative Study Between Porcine and Autologous Cortical Plates	N/A
Completed	`NCT03432702` - Horizontal Ridge Augmentation With or Without Autogenous Block Grafts	N/A
Terminated	`NCT02387008` - Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous Space	N/A
Recruiting	`NCT04937023` - Ursodeoxycholic Acid (Udca) as a Local Drug Delivery Agent in the Treatment of Intra-bony Defects	N/A
Completed	`NCT05791123` - Alveolar Ridge Augmentation Following Tooth Extraction Using Bovine Xenograft With Platelet Rich Fibrin Membrane	N/A
Recruiting	`NCT06168500` - Narrow Implants Vs Standard Implants With Simultaneous GBR	N/A
Terminated	`NCT00435877` - Procurement of Tissue Samples for Cell Cultures and Analyses
Completed	`NCT03391258` - Guided Bone Regeneration With L-PRF in the Atrophic Maxilla - The GLAM Technique	N/A
Completed	`NCT03496688` - Comparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus	N/A
Completed	`NCT04843488` - Effectiveness of Different Membrane Applications in Vertical Ridge Augmentation	N/A
Active, not recruiting	`NCT04338139` - Influence of Bio-Oss Collagen Grafting at Implant Placement on Buccal Bone Volume Regeneration	N/A
Active, not recruiting	`NCT06226116` - COMPARATIVE STUDY OF BONE IMPLANT CONTACT (BIC) ON NEW BONE REGENERATED WITH AUTOGENOUS DENTIN AND NATIVE BONE	N/A
Completed	`NCT04131894` - Effects of Autogenous Dentin Graft on Socket Preservation	Phase 4
Recruiting	`NCT06061354` - Teriparatide on Maxillary Sinus Floor Osseointegration	Phase 4
Completed	`NCT03785717` - Horizontal Ridge Augmentation in Mandible Usign ROG + ESWT	N/A
Completed	`NCT02890680` - Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery	N/A
Recruiting	`NCT06383377` - Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

In Vivo Investigation of 6 Membranes Including Their Physical, Chemical and Biological Properties.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms